ATE238787T1 - Caspases und apoptosis - Google Patents
Caspases und apoptosisInfo
- Publication number
- ATE238787T1 ATE238787T1 AT98939138T AT98939138T ATE238787T1 AT E238787 T1 ATE238787 T1 AT E238787T1 AT 98939138 T AT98939138 T AT 98939138T AT 98939138 T AT98939138 T AT 98939138T AT E238787 T1 ATE238787 T1 AT E238787T1
- Authority
- AT
- Austria
- Prior art keywords
- caspases
- apoptosis
- Prior art date
Links
- 102000011727 Caspases Human genes 0.000 title 1
- 108010076667 Caspases Proteins 0.000 title 1
- 230000006907 apoptotic process Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5424997P | 1997-07-30 | 1997-07-30 | |
| PCT/US1998/015909 WO1999006042A1 (en) | 1997-07-30 | 1998-07-30 | Caspases and apoptosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE238787T1 true ATE238787T1 (de) | 2003-05-15 |
Family
ID=21989752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98939138T ATE238787T1 (de) | 1997-07-30 | 1998-07-30 | Caspases und apoptosis |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6214858B1 (de) |
| EP (1) | EP0988035B1 (de) |
| JP (1) | JP2001511449A (de) |
| AR (1) | AR016551A1 (de) |
| AT (1) | ATE238787T1 (de) |
| AU (1) | AU8762898A (de) |
| CA (1) | CA2298668A1 (de) |
| CO (1) | CO4970744A1 (de) |
| DE (1) | DE69814072T2 (de) |
| ES (1) | ES2198739T3 (de) |
| IL (1) | IL132771A0 (de) |
| WO (1) | WO1999006042A1 (de) |
| ZA (1) | ZA986761B (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6808902B1 (en) | 1999-11-12 | 2004-10-26 | Amgen Inc. | Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
| EP1261364A1 (de) * | 2000-02-10 | 2002-12-04 | Wyeth | Methode zur behandlung von zellverletzung oder zelltod |
| US9219708B2 (en) * | 2001-03-22 | 2015-12-22 | DialwareInc. | Method and system for remotely authenticating identification devices |
| EP2295081B1 (de) | 2001-06-26 | 2018-10-31 | Amgen Inc. | Antikörper gegen OPGL |
| AU2003225088A1 (en) * | 2002-04-19 | 2003-11-03 | Vertex Pharmaceuticals Incorporated | Regulation of tnf-alpha |
| CA2490409A1 (en) | 2002-06-28 | 2004-01-08 | Centocor, Inc. | Mammalian ch1 deleted mimetibodies, compositions, methods and uses |
| KR101317045B1 (ko) | 2002-09-06 | 2013-10-16 | 암젠 인코포레이티드 | 치료학적 인체 항-ｉｌ-1ｒ1 모노클로날 항체 |
| RU2233326C1 (ru) * | 2002-11-26 | 2004-07-27 | Институт органической химии им. Н.Д. Зелинского РАН | Способ ингибирования каспаз |
| RU2232809C1 (ru) * | 2002-11-26 | 2004-07-20 | Институт органической химии им. Н.Д. Зелинского РАН | Способ прямого ингибирования каспаз |
| US20060251638A1 (en) * | 2003-06-06 | 2006-11-09 | Volkmar Guenzler-Pukall | Cytoprotection through the use of hif hydroxylase inhibitors |
| BRPI0415616A (pt) * | 2003-10-21 | 2006-12-12 | Aga Ab | uso do xenÈnio para a prevenção da morte programada da célula |
| US7256198B2 (en) | 2004-02-18 | 2007-08-14 | Wyeth | Pyrimidoindolones and methods for using same |
| AU2005228950B2 (en) * | 2004-03-23 | 2012-02-02 | Genentech, Inc. | Azabicyclo-octane inhibitors of IAP |
| RU2311180C2 (ru) * | 2005-04-28 | 2007-11-27 | Галина Викторовна Сукоян | Средство для предотвращения прогрессирования апоптотических и купирования некротических изменений в тканях организма |
| SG10201500180RA (en) * | 2009-05-29 | 2015-03-30 | Xoma Us Llc | CARDIOVASCULAR RELATED USES OF IL-1ß ANTIBODIES AND BINDING FRAGMENTS THEREOF |
| US20130109672A1 (en) * | 2010-04-29 | 2013-05-02 | The United States Of America,As Represented By The Secretary, Department Of Health And Human Service | Activators of human pyruvate kinase |
| US12403181B2 (en) | 2018-08-13 | 2025-09-02 | Iltoo Pharma | Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof |
| WO2023222565A1 (en) | 2022-05-16 | 2023-11-23 | Institut National de la Santé et de la Recherche Médicale | Methods for assessing the exhaustion of hematopoietic stems cells induced by chronic inflammation |
| CN120661507B (zh) * | 2025-08-25 | 2025-11-11 | 广州市老人院(加挂广州市第二老人院和广州市老年医院牌子) | 1-((4-环己基苯基)磺酰基)-n-(4-氟苄基)-4-甲基哌啶-4-甲酰胺在制备治疗神经系统疾病药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5164404A (en) * | 1991-03-15 | 1992-11-17 | Neurosearch A/S | Hydrazone derivatives and their use |
| EP0533226A3 (en) * | 1991-08-16 | 1993-08-18 | Merck & Co. Inc. | Novel chromophore containing compounds |
| US5763220A (en) | 1996-12-12 | 1998-06-09 | Incyte Pharmaceuticals, Inc. | Human apoptosis-related calcium-binding protein |
| AR016384A1 (es) * | 1997-07-30 | 2001-07-04 | Smithkline Beecham Corp | Inhibidores de caspasas, composiciones farmaceuticas que comprenden dichos inhibidores de caspasas y uso de los inhibidores de caspasas para prepararun medicamento util para el tratamiento de apoptosis y desordenes asociados con excesiva actividad de la convertosa il-1 beta. |
-
1998
- 1998-07-28 AR ARP980103698A patent/AR016551A1/es unknown
- 1998-07-29 CO CO98043136A patent/CO4970744A1/es unknown
- 1998-07-29 ZA ZA986761A patent/ZA986761B/xx unknown
- 1998-07-30 WO PCT/US1998/015909 patent/WO1999006042A1/en not_active Ceased
- 1998-07-30 AU AU87628/98A patent/AU8762898A/en not_active Abandoned
- 1998-07-30 ES ES98939138T patent/ES2198739T3/es not_active Expired - Lifetime
- 1998-07-30 DE DE69814072T patent/DE69814072T2/de not_active Expired - Fee Related
- 1998-07-30 US US09/445,556 patent/US6214858B1/en not_active Expired - Fee Related
- 1998-07-30 CA CA002298668A patent/CA2298668A1/en not_active Abandoned
- 1998-07-30 EP EP98939138A patent/EP0988035B1/de not_active Expired - Lifetime
- 1998-07-30 IL IL13277198A patent/IL132771A0/xx unknown
- 1998-07-30 JP JP2000504856A patent/JP2001511449A/ja not_active Withdrawn
- 1998-07-30 AT AT98939138T patent/ATE238787T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0988035A1 (de) | 2000-03-29 |
| EP0988035A4 (de) | 2001-09-19 |
| CA2298668A1 (en) | 1999-02-11 |
| AU8762898A (en) | 1999-02-22 |
| JP2001511449A (ja) | 2001-08-14 |
| AR016551A1 (es) | 2001-07-25 |
| DE69814072T2 (de) | 2004-03-11 |
| DE69814072D1 (de) | 2003-06-05 |
| ES2198739T3 (es) | 2004-02-01 |
| ZA986761B (en) | 1999-02-01 |
| CO4970744A1 (es) | 2000-11-07 |
| IL132771A0 (en) | 2001-03-19 |
| US6214858B1 (en) | 2001-04-10 |
| WO1999006042A1 (en) | 1999-02-11 |
| EP0988035B1 (de) | 2003-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69738197D1 (de) | Azolotriazine und pyrimidine | |
| DE69828963D1 (de) | Wirstoffabgabe und gentherapiesystem | |
| DE69826825D1 (de) | Schaltungsanordnung und zugehörige signalleuchte | |
| DE19983771T1 (de) | Elektrochrome Gebilde und Strukturen | |
| DE69924002D1 (de) | Kompressions-abgestimmtes bragggitter und kompressions-abgestimmter laser | |
| DE69834616D1 (de) | Tastsinnempfindlicher detektor und signalisierungseinheit | |
| DE69819812D1 (de) | Fahrradschalter und Gehäuse dafür | |
| PT946323E (pt) | Pos de niobio e condensadores eletroliticos de niobio | |
| DE69913169D1 (de) | Sportschuh und dafür vorgesehene dornen | |
| DE69738784D1 (de) | Konstruktionselemente | |
| ATE238787T1 (de) | Caspases und apoptosis | |
| NO20000125L (no) | Tiadiazolyl- og oksadiazolylfenyloksazolidinon- antibakterielle midler | |
| DE69831750D1 (de) | Biozide und biozide tücher | |
| DE69833304D1 (de) | Gesamt-optische Zeitdemultiplex-Schaltung und gesamtoptische TDM-WDM Konversionsschaltung | |
| DE59804804D1 (de) | Optisches schaltelement und schaltanordnung | |
| ZA986760B (en) | Caspases and apoptosis | |
| DE69833414D1 (de) | Modulator und Demodulator | |
| DE69916694D1 (de) | 2-Hydroxy-5-methyl-hexan-3-on und 3-hydroxy-5-methyl-hexan-2-on | |
| EP1087663A4 (de) | Caspasen und apoptose | |
| DE69730545D1 (de) | Arithmetische Einheit | |
| NO315610B3 (no) | Azolotriaziner og -pyrimidiner | |
| EP1242081A4 (de) | Caspases und apoptose | |
| PT958285E (pt) | Benzo¬e|isoindois e benzo¬h|isoquinolinas triciclicos | |
| DE69842206D1 (de) | Echounterdrücker und echounterdrückungsverfahren | |
| DE69905027D1 (de) | N-sulphonyl und n-sulphinyl phenylglycinamide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |